REAL3 Trial of Efficacy of EOX With/Without Panitumumab in Previously Untreated Adv OG Cancer

This study has been terminated.
(Lack of efficacy)
Sponsor:
Information provided by (Responsible Party):
Professor David Cunningham, Royal Marsden NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT00824785
First received: January 16, 2009
Last updated: December 10, 2012
Last verified: December 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: February 2013
  Estimated Primary Completion Date: February 2013 (Final data collection date for primary outcome measure)
No publications provided by Royal Marsden NHS Foundation Trust

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):